Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Research Partnership is on the rise

December 21, 2021 | Mark Jeffrey, Pharma, global healthcare 

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

The UK’s best performing market research agencies were revealed this week with the publication of Research Live’s Industry Report for 2021, which includes the latest Market Research Society (MRS) League Tables. Based on available 2020 financial data that was compiled and analysed in November 2021, the MRS league tables identify and rank the best-performing research agencies and businesses according to their UK-based turnover and by their year-on-year growth.

In a very challenging year globally, Research Partnership bucked the trend by achieving an impressive 21% growth against an industry average of 0.8%. Less than half of the top 100 companies reported any growth.

Research Partnership ranked 23rd in the top individual agencies with a confirmed turnover of £40.297m and remains the UK’s largest individual healthcare consulting specialist.

The company ranked 7th in the top 20 fastest-growing businesses and 12th in the top 20 fastest-growing individual agencies.

Joint Founding Director Mark Jeffery commented, “Research Partnership has achieved considerable growth in a very turbulent climate. Fortunately, we were able to pivot quickly to remote working using online methodologies and we responded effectively to increased demand from our clients. Last year, we continued our recruitment drive and increased our headcount from 216 to 250 with appointments made across the US, EU and APAC offices. We also continued to grow both our market research and market access services, and we are winning business from both new and existing clients across the pharmaceutical, medtech and biotech sectors. According to our customer survey, satisfaction with insights and recommendations remained high and we are still delivering the quality service expected of us.”

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...